Schedule 13G ownership disclosure

C4 Therapeutics Inc

Common Stock · CUSIP: 12529R107

Event date: 2025-04-30

Filing-level shares
7,473,332.00
Percent of class
10.5%
  • WASATCH ADVISORS LP

    Shares: 7,473,332.00 · Class: 10.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000814133-25-000035
Form type
SCHEDULE 13G/A
Filer
C4 Therapeutics, Inc.
CIK
CIK 1662579
Filed
May 07, 2025
Reporting period
Apr 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub